معرفی
Professor Katie Lunnon serves as Professor of Dementia Genomics at the University of Exeter Medical School, where she leads the Complex Disease Epigenetics Group and Mill Epigenetics Group. Her research focuses on genomic mechanisms in dementia, with particular emphasis on epigenetic regulation and biomarker discovery for Alzheimer's disease.
Her academic qualifications include:
- BSc Biochemistry & Pharmacology (First Class Honors), University of Southampton, 2004
- PhD Neuroscience, University of Southampton, 2008
- PGCAP, King's College London, 2010
Professor Lunnon's work centers on DNA methylation patterns in dementia, investigating how epigenetic modifications contribute to disease pathogenesis. Her research spans biomarker identification for early detection, mitochondrial dysfunction mechanisms, and neuroinflammatory processes in Alzheimer's disease. She pioneered the first genome-wide cross-tissue methylomic study in Alzheimer's, bridging molecular biology with clinical neuroscience to advance diagnostic and therapeutic strategies.
No scientific awards are specified in the provided documentation.
The available information does not detail specific grants or student supervision activities.
She directs the Mill Epigenetics Group and Complex Disease Epigenetics Group, utilizing cutting-edge genomic technologies to unravel epigenetic mechanisms in dementia and develop translational applications for early intervention.
